The Procter & Gamble Company (NYSE:PG) Position Reduced by Ghe LLC

Ghe LLC reduced its position in shares of The Procter & Gamble Company (NYSE:PG) by 27.4% in the third quarter, HoldingsChannel.com reports. The firm owned 8,724 shares of the company’s stock after selling 3,291 shares during the period. Ghe LLC’s holdings in Procter & Gamble were worth $1,511,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of PG. Concurrent Investment Advisors LLC boosted its position in shares of Procter & Gamble by 4.5% in the 3rd quarter. Concurrent Investment Advisors LLC now owns 94,109 shares of the company’s stock valued at $16,300,000 after purchasing an additional 4,035 shares during the period. Radnor Capital Management LLC acquired a new stake in shares of Procter & Gamble during the third quarter valued at approximately $5,705,000. Welch Group LLC lifted its position in shares of Procter & Gamble by 0.9% in the 3rd quarter. Welch Group LLC now owns 323,870 shares of the company’s stock valued at $56,094,000 after acquiring an additional 2,990 shares in the last quarter. GAMMA Investing LLC boosted its stake in Procter & Gamble by 67.2% in the 2nd quarter. GAMMA Investing LLC now owns 26,803 shares of the company’s stock worth $4,420,000 after purchasing an additional 10,777 shares during the period. Finally, Quintet Private Bank Europe S.A. raised its stake in Procter & Gamble by 15.0% during the 3rd quarter. Quintet Private Bank Europe S.A. now owns 426,820 shares of the company’s stock valued at $73,925,000 after purchasing an additional 55,620 shares during the period. Institutional investors own 65.77% of the company’s stock.

Procter & Gamble Stock Performance

Shares of NYSE PG traded up $0.31 during trading hours on Wednesday, hitting $166.15. 81,612 shares of the company’s stock were exchanged, compared to its average volume of 6,634,311. The stock has a market capitalization of $391.29 billion, a price-to-earnings ratio of 28.59, a PEG ratio of 3.59 and a beta of 0.42. The company’s 50-day moving average price is $170.79 and its 200-day moving average price is $168.29. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.75 and a quick ratio of 0.55. The Procter & Gamble Company has a 1-year low of $142.50 and a 1-year high of $177.94.

Procter & Gamble (NYSE:PG) last issued its quarterly earnings results on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.90 by $0.03. The firm had revenue of $21.74 billion for the quarter, compared to analyst estimates of $21.99 billion. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The company’s quarterly revenue was down .6% compared to the same quarter last year. During the same period in the previous year, the company posted $1.83 earnings per share. On average, sell-side analysts expect that The Procter & Gamble Company will post 6.94 earnings per share for the current fiscal year.

Procter & Gamble Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be paid a $1.0065 dividend. The ex-dividend date of this dividend is Friday, October 18th. This represents a $4.03 dividend on an annualized basis and a yield of 2.42%. Procter & Gamble’s payout ratio is currently 69.48%.

Wall Street Analysts Forecast Growth

A number of research analysts have recently weighed in on PG shares. JPMorgan Chase & Co. lifted their price target on Procter & Gamble from $179.00 to $186.00 and gave the company an “overweight” rating in a report on Thursday, September 19th. Deutsche Bank Aktiengesellschaft lifted their target price on Procter & Gamble from $171.00 to $176.00 and gave the company a “buy” rating in a research note on Wednesday, July 17th. Barclays cut shares of Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 price target for the company. in a report on Monday, September 30th. TD Cowen initiated coverage on shares of Procter & Gamble in a research note on Tuesday, July 23rd. They issued a “buy” rating and a $189.00 price objective on the stock. Finally, Dbs Bank lowered shares of Procter & Gamble from a “strong-buy” rating to a “hold” rating in a research note on Thursday, August 1st. Nine research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $177.00.

Insider Buying and Selling

In other Procter & Gamble news, insider Balaji Purushothaman sold 12,800 shares of the stock in a transaction on Thursday, October 24th. The stock was sold at an average price of $168.99, for a total transaction of $2,163,072.00. Following the completion of the transaction, the insider now directly owns 11,566 shares in the company, valued at $1,954,538.34. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. In other news, CEO Jon R. Moeller sold 31,797 shares of the company’s stock in a transaction that occurred on Tuesday, August 20th. The shares were sold at an average price of $169.22, for a total transaction of $5,380,688.34. Following the transaction, the chief executive officer now directly owns 300,777 shares in the company, valued at approximately $50,897,483.94. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Balaji Purushothaman sold 12,800 shares of the company’s stock in a transaction on Thursday, October 24th. The stock was sold at an average price of $168.99, for a total value of $2,163,072.00. Following the transaction, the insider now directly owns 11,566 shares in the company, valued at approximately $1,954,538.34. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 313,597 shares of company stock valued at $53,268,499 over the last quarter. Corporate insiders own 0.18% of the company’s stock.

About Procter & Gamble

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.